“Lebrikizumab Improves Atopic Dermatitis and ​Quality of Life in Patients With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab: ​ Results From the ADapt Trial”. SKIN The Journal of Cutaneous Medicine 9, no. 1 (January 13, 2025): s512. Accessed May 30, 2025. https://skin.dermsquared.com/skin/article/view/3151.